Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
21 participants
OBSERVATIONAL
2017-08-13
2018-08-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Microcirculation-assisted Adjustment of Blood Flow of VA-ECMO on Prognosis
NCT03470792
Measuring Energy Expenditure in ECMO (Extracorporeal Membrane Oxygenation) Patients
NCT01992237
Effect of Transpulmonary MP on Prognosis of Patients With Severe ARDS Treated With VV-ECMO
NCT06062212
Enhanced Lung Protective Ventilation With ECCO2R During ARDS
NCT03525691
Low Frequency, Ultra-low Tidal Volume Ventilation in Patients With ARDS and ECMO
NCT03764319
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Measurment of blood recirculation
Ultrasound based measurments of blood recirculating through the vvECMO circuit.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ARDS
* veno-venous ECMO
Exclusion Criteria
* hemodynamic instability during measurement of recirculation
* pregnancy
* inability to obtain patient's consent or consent of legal guardian
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Charite University, Berlin, Germany
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Steffen Weber-Carstens
Prof. Dr. med.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Martin Russ, Dr. med.
Role: PRINCIPAL_INVESTIGATOR
Charite University Hospital Berlin
Philipp A Pickerodt, Dr. med.
Role: PRINCIPAL_INVESTIGATOR
Charite University Hospital Berlin
Steffen Weber-Carstens, PD Dr. med.
Role: PRINCIPAL_INVESTIGATOR
Charite University Hospital Berlin
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Charite University, Berlin, Germany
Berlin, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EA208317
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.